Summary:
- The article discusses the Covishield vaccine, which was developed by the Serum Institute of India in partnership with AstraZeneca and the University of Oxford.
- It explains the controversy around the Covishield vaccine, including issues with the clinical trials and the vaccine's efficacy.
- The article also highlights the importance of the Covishield vaccine in India's COVID-19 vaccination program and the challenges faced in its distribution and administration.